Novel heteroaryl and heterocycle compounds, compositions and methods thereof
OwnerWei-Guo SU, Guangxiu DAI +6inventors
InventorsWei-Guo SU, Guangxiu DAI, Kun XIAO, Hong JIA, Zhulin ZHANG, Jennifer Diane VENABLE, Scott Damian BEMBENEK, Wenying CHAI
Life of this patent
Estimating the term…
Abstract
Disclosed are novel heteroaryl and heterocycle compounds of formula I-1, I-2 or I-3 and pharmaceutical compositions comprising them, uses and methods thereof for inhibiting the activity of PI3K and for treating inflammatory and autoimmune diseases and cancer.
Claims39
A compound of formula I-1, I-2 or I-3:
- and/or its solvates, racemic mixture, enantiomers, diasteromers, tautomers, or mixtures of any ratio, or pharmaceutically acceptable salts thereof, wherein:
- Z═N or CH;
- R1 is selected from optionally substituted C1-6 alkyl, optionally substituted C3-6 cycloalkyl, —(CR′R″)n-heterocycle, —(CR′R″)n-aryl, and —(CR′R″)n-heteroaryl, wherein heterocycle, aryl and heteroaryl independently are 5-6 membered monocyclic ring, which are optionally substituted with one or more groups selected from hydrogen, halo, optionally substituted C1-6 alkyl, optionally substituted C1-6 alkoxyl, —CN, —CF3, and —SO2R′;
- R2 and R3 are each independently selected from hydrogen and optionally substituted C1-4 alkyl;
- R4 is selected from hydrogen, halo, —CN, optionally substituted C1-6 alkyl, optionally substituted C3-6 cycloalkyl, optionally substituted C2-6 alkenyl, optionally substituted C2-6 alkynyl, —C(O)NR′R″, and optionally substituted 5-6 membered monocyclic heteroaryl;
- R5 is selected from hydrogen and optionally substituted C1-4 alkyl;
- or R3, R5 and the atoms they are attached to form an optionally substituted 4-6 membered mono- or bicyclic saturated or partially unsaturated heterocyclic ring;
- R′ and R″ are each independently selected from hydrogen, halo, optionally substituted C1-6 alkyl, optionally substituted C3-6 cycloalkyl, and optionally substituted 4-6 membered monocyclic heterocycle;
- or R′, R″ and the nitrogen or carbon atom they are both attached to form an optionally substituted 3-7 membered heterocycle;
- each of m and n is 0, 1, 2, or 3;
- each of p is 1 or 2;
- W is a heteroaryl, which is optionally substituted with one or more groups selected from halo, —CN, —CF3, —NO2, —OR′, —NR′R″, —NR′COR″, —(CR′R″)n—C(O)R′, —(CR′R″)n—C(═N—OR′)—R″, —(CR′R″)n—C(O)NR′R″, —(CR′R″)n—S(O)pR′, —(CR′R″)n—SR′, optionally substituted C1-6 alkyl, optionally substituted C2-6 alkenyl, optionally substituted C2-6 alkynyl, optionally substituted C1-6 alkoxy, optionally substituted 5-6 membered monocyclic heterocycle, and optionally substituted 5-6 membered monocyclic heteroaryl;
- provided that for formula I-1, when Z═N, R3, R5 and the atoms they are attached to must form an optionally substituted 4-6 membered mono- or bicyclic saturated or partially unsaturated heterocyclic ring, with the provision that when R3, R5 and the atoms they are attached to form an optionally substituted 5 membered mono- or bicyclic saturated or partially unsaturated heterocyclic ring, R4 is not hydrogen, —CN, or aminomethyl.
At least one compound selected from compounds 1 to 521 and/or at least one its solvates, racemic mixture, enantiomers, diasteromers, tautomers, or mixtures of any ratio, or pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.